Yusuf Dolen

5PUBLICATIONS
43CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 23, 2025
Galectin-9 regulates dendritic cell polarity and uropod contraction by modulating RhoA activity.

Guus A Franken, Harry Warner, Jorge Cuenca-Escalona

|Nov 28, 2024
Galectin-9 regulates dendritic cell polarity and uropod contraction by modulating RhoA activity.

Guus Franken, Jorge Cuenca-Escalona, Isabel Stehle

|Apr 16, 2022
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.

Camille Le Gall, Anna Cammarata, Lukas de Haas

|Dec 05, 2019
Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-lived effector cells.

M Valente, Y Dölen, E van Dinther

|Sep 07, 2019
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering.

Johan M S van der Schoot, Felix L Fennemann, Michael Valente

Pageof 1